Kalhara Menikdiwela

Dr. Kalhara Menikdiwela

Texas Tech University, Lubbock, Texas, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2018 in Obesity
Verified
Journal Article
Open access
PDF file
LRLatha Ramalingam
Latha Ramalingam
KMKalhara Menikdiwela
Kalhara Menikdiwela
SCStephani Clevenger
Stephani Clevenger
TETochi Eboh
Tochi Eboh
LALondon Allen
London Allen
Naima Moustaid-MoussaNaima Moustaid-Moussa
Naima Moustaid-Moussa
Objective: Over half of American women of childbearing age have either obesity or overweight. Hence, maternal programming through diet is critical for prevention of diseases in the offspring. Clinical trials with fish oil (FO) report various health benefits; however, it remains unclear whether maternal and postnatal consumption of FO protects offspring from adverse effects of consuming a high‐fat (HF) diet.Methods: Female mice were fed HF diets supplemented without (HF) or with FO from 8 weeks before pregnancy through lactation. A low‐fat (LF) diet was included as a control diet. After weaning, male offspring from HF or FO dams were either continued on their respective diet (HF‐HF and FO‐FO) or switched to the other diet (HF‐FO and FO‐HF) and compared with LF. Phenotypic and mechanistic studies were performed.Results: FO‐FO offspring demonstrated significantly higher glucose clearance and insulin sensitivity compared with other pups fed the HF diet (P < 0.05). Furthermore, FO‐FO pups had lower adiposity, inflammation, and fat deposition in the liver, consistent with reduced markers of hepatic lipogenesis and increased hepatic lipid oxidation.Conclusions: Supplementation of FO during pregnancy and early life is more beneficial than treating with FO either during pregnancy or in pups.

26 May 2020 in Cells
Verified
Journal Article
Open access
PDF file
KMKalhara Menikdiwela
Kalhara Menikdiwela
LRLatha Ramalingam
Latha Ramalingam
MAMostafa M. Abbas
Mostafa M. Abbas
HBHalima Bensmail
Halima Bensmail
SSShane Scoggin
Shane Scoggin
Naima Moustaid-MoussaNaima Moustaid-Moussa
Naima Moustaid-Moussa
Overactivation of the renin–angiotensin system (RAS) during obesity disrupts adipocyte metabolic homeostasis and induces endoplasmic reticulum (ER) stress and inflammation; however, underlying mechanisms are not well known. We propose that overexpression of angiotensinogen (Agt), the precursor protein of RAS in adipose tissue or treatment of adipocytes with Angiotensin II (Ang II), RAS bioactive hormone, alters specific microRNAs (miRNA), that target ER stress and inflammation leading to adipocyte dysfunction. Epididymal white adipose tissue (WAT) from B6 wild type (Wt) and transgenic male mice overexpressing Agt (Agt-Tg) in adipose tissue and adipocytes treated with Ang II were used. Small RNA sequencing and microarray in WAT identified differentially expressed miRNAs and genes, out of which miR-690 and mitogen-activated protein kinase kinase 3 (MAP2K3) were validated as significantly up- and down-regulated, respectively, in Agt-Tg, and in Ang II-treated adipocytes compared to respective controls. Additionally, the direct regulatory role of miR-690 on MAP2K3 was confirmed using mimic, inhibitors and dual-luciferase reporter assay. Downstream protein targets of MAP2K3 which include p38, NF-κB, IL-6 and CHOP were all reduced. These results indicate a critical post-transcriptional role for miR-690 in inflammation and ER stress. In conclusion, miR-690 plays a protective function and could be a useful target to reduce obesity.

21 October 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
LRLatha Ramalingam
Latha Ramalingam
KMKalhara Menikdiwela
Kalhara Menikdiwela
SSStephani Spainhour
Stephani Spainhour
TETochi Eboh
Tochi Eboh
Naima Moustaid-MoussaNaima Moustaid-Moussa
Naima Moustaid-Moussa
Pre-pregnancy obesity is a contributing factor for impairments in offspring metabolic health. Interventional strategies during pregnancy are a potential approach to alleviate and/or prevent obesity and obesity related metabolic alterations in the offspring. Fish oil (FO), rich in omega-3 polyunsaturated fatty acids (n-3 PUFAs) exerts metabolic health benefits. However, the role of FO in early life remains still unknown. Hence, this study objective was to determine the effect of FO supplementation in mice from pre-pregnancy through lactation, and to study the post-natal metabolic health effects in gonadal fat and liver of offspring fed high fat (HF) diet with or without FO. Female C57BL6J mice aged 4–5 weeks were fed a HF (45% fat) diet supplemented with or without FO (30 g/kg of diet) and low fat (LF; 10% fat) pre-pregnancy through lactation. After weaning, offspring (male and female) from HF or FO dams either continued the same diet (HF-HF and FO-FO) or switched to the other diet (HF-FO and FO-HF) for 13 weeks, creating four groups of treatment, and LF-LF was used as a control group. Serum, gonadal fat and liver tissue were collected at termination for metabolic analyses. Offspring of both sexes fed HF with or without fish oil gained (p < 0.05) more weight post weaning, compared to LF-LF-fed mice. All the female offspring groups supplemented with FO had reduced body weight compared to the respective male groups. Further, FO-FO supplementation in both sexes (p < 0.05) improved glucose clearance and insulin sensitivity compared to HF-HF. All FO-FO fed mice had significantly reduced adipocyte size compared to HF-HF group in both male and females. Inflammation, measured by mRNA levels of monocyte chemoattractant protein 1 (Mcp1), was reduced (p < 0.05) with FO supplementation in both sexes in gonadal fat and in the liver. Markers of fatty acid synthesis, fatty acid synthase (Fasn) showed no sex specific differences in gonadal fat and liver of mice supplemented with HF. Female mice had lower liver triglycerides than male counterparts. Supplementation of FO in mice improved metabolic health of offspring by lowering markers of lipid synthesis and inflammation.

1 August 2021 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
JPJacaline K. Parkman
Jacaline K. Parkman
KSKristiana Sklioutovskaya-Lopez
Kristiana Sklioutovskaya-Lopez
KMKalhara Menikdiwela
Kalhara Menikdiwela
LFLogan Freeman
Logan Freeman
Naima Moustaid-MoussaNaima Moustaid-Moussa
Naima Moustaid-Moussa
JKJung Han Kim
Jung Han Kim

15 November 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
KMKalhara Menikdiwela
Kalhara Menikdiwela
CKChanaka Kahathuduwa
Chanaka Kahathuduwa
MBMichelle L. Bolner
Michelle L. Bolner
RRRakhshanda` Layeequr Rahman
Rakhshanda` Layeequr Rahman
Naima Moustaid-MoussaNaima Moustaid-Moussa
Naima Moustaid-Moussa
Luminal breast cancers are the most common genomic subtype of breast cancers where Luminal A cancers have a better prognosis than Luminal B. Exposure to sex steroids and inflammatory status due to obesity are key contributors of Luminal tumor development. In this study, 1928 patients with Luminal A breast cancer and 1610 patients with Luminal B breast cancer were compared based on body mass index (BMI), age, race, menopausal status, and expressed receptors (i.e., estrogen (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER2)). Patients with Luminal B tumors had a significantly higher mean BMI (Δ = 0.69 kgm−2 [0.17, 1.21], p = 0.010) versus Luminal A. Interestingly, the risks of Luminal B tumors were higher among Black/African American patients versus White and Hispanic patients (p < 0.001 and p = 0.001, respectively). When controlled for each other, Black/African American race (p < 0.001) and increased BMI (p = 0.008) were associated with increased risks of Luminal B carcinoma, while postmenopausal status was associated with a decreased risk (p = 0.028). Increased BMI partially mediated the strong association between Black/African American race and the risk of Luminal B carcinoma. Thus, Black/African American race along with obesity seem to be associated with an increased risk of more aggressive Luminal B breast carcinomas.

22 June 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
KMKalhara Menikdiwela
Kalhara Menikdiwela
JGJoão Pedro Tôrres Guimarães
João Pedro Tôrres Guimarães
SSShane Scoggin
Shane Scoggin
LGLauren S Gollahon
Lauren S Gollahon
Naima Moustaid-MoussaNaima Moustaid-Moussa
Naima Moustaid-Moussa
(1) Consumption of diets that are caloric dense but not nutrient dense have been implicated in metabolic diseases, in part through low-grade metabolic acidosis. Mitigation strategies through dietary intervention to alleviate acidosis have not been previously reported. Our objective is to determine the effects of pH enhancement (with ammonia) in high fat diet-induced obese mice that were fed beef or casein as protein sources compared to low fat diet-fed mice. (2) Methods: B6 male and female mice were randomized (n = 10) into eight diets that differ in protein source, pH enhancement of the protein, and fat content, and fed for 13 weeks: low fat (11% fat) casein (LFC), LF casein pH-enhanced (LFCN), LF lean beef (LFB), LFBN, high fat (46%) casein (HFC), HFCN, HF beef (HFB), and HFBN. Body weights and composition, and glucose tolerance tests were conducted along with terminal serum analyses. Three-way ANOVA was performed. (3) Results: A significant effect of dietary fat (LF vs. HF) was observed across all variables in both sexes (final body weight, fat mass, glucose clearance, and serum leptin). Importantly, pH enhancement significantly reduced adiposity (males only) and final body weights (females only) and significantly improved glucose clearance in both sexes. Lastly, clear sex differences were observed across all variables. (4) Conclusions: Our findings demonstrate metabolic benefits of increasing dietary pH using ammonia, while high fat intake per se (not protein source) is the major contributor to metabolic dysfunctions. Additional research is warranted to determine mechanisms underlying the beneficial effects of pH enhancement, and interactions with dietary fat content and proteins.